Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,528.52
(
2.91%
)
US TECH 100
23,134.80
(
3.60%
)
Dow Jones
46,341.51
(
2.49%
)
Brent Oil
103.14
(
-5.00%
)
Bitcoin
68,245.29
(
2.31%
)
News Focus
News Focus
Post# of 257323
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

EYEBUYSTOX

Send PM Follow Ignore
Followers 48
Posts 3935
Boards Moderated 0
Alias Born 01/26/2011

EYEBUYSTOX

Re: mcbio post# 146843

Thursday, 08/09/2012 7:33:47 PM

Thursday, August 09, 2012 7:33:47 PM

Post# of 257323
The reason I have to believe that there will be CRs is that in the last update, the CEO mentioned there were several patients still receiving maintenance therapy of bavituximab. This is only allowed under the trial design if disease has not progressed. All, IMO.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today